The relationship between motor cortex excitability and severity of Alzheimer's disease: A transcranial magnetic stimulation study
暂无分享,去创建一个
E. M. Khedr | E. Khedr | M. Ahmed | Essam S. Darwish | Mohamed A. Ahmed | E. S. Darwish | A. Ali | M. A. Ahmed | A. M. Ali | Anwar M. Ali | A. M. Ali
[1] Maria Grazia Marciani,et al. Effect of Vigabatrin on motor responses to transcranial magnetic stimulation An effective tool to investigate in vivo GABAergic cortical inhibition in humans , 2004, Brain Research.
[2] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[3] J. Liepert,et al. Orally administered atropine enhances motor cortex excitability: a transcranial magnetic stimulation study in human subjects , 2001, Neuroscience Letters.
[4] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[5] B. Christensen,et al. The mechanisms of interhemispheric inhibition in the human motor cortex , 2002, The Journal of physiology.
[6] M. Albert,et al. Neurobiological Bases of Age-Related Cognitive Decline in the Rhesus Monkey , 1996, Journal of neuropathology and experimental neurology.
[7] Raffaele Ferri,et al. Motor cortex excitability in Alzheimer disease: one year follow-up study , 2002, Neuroscience Letters.
[8] P. Fitzgerald,et al. A study of transcallosal inhibition in schizophrenia using transcranial magnetic stimulation , 2002, Schizophrenia Research.
[9] R. Duara,et al. [Cerebral white matter bundle alterations in patients with dementia of Alzheimer type and patients with multi-infarct dementia--magnetic resonance imaging study]. , 1990, Rinsho shinkeigaku = Clinical neurology.
[10] G Gainotti,et al. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[11] J. Morris. The Clinical Dementia Rating (CDR) , 1993, Neurology.
[12] C. Culmsee,et al. Cellular and Molecular Mechanisms Underlying Perturbed Energy Metabolism and Neuronal Degeneration in Alzheimer's and Parkinson's Diseases , 1999, Annals of the New York Academy of Sciences.
[13] G. V. Van Hoesen,et al. Alzheimer's disease: Glutamate depletion in the hippocampal perforant pathway zone , 1987, Annals of neurology.
[14] J. Liepert,et al. Motor cortex disinhibition in Alzheimer's disease , 2001, Clinical Neurophysiology.
[15] Pedro C. Miranda,et al. Magnetic stimulation in Alzheimer’s disease , 1997, Journal of Neurology.
[16] P. Delwaide,et al. Motor cortex inhibition is not impaired in patients with Alzheimer’s disease: evidence from paired transcranial magnetic stimulation , 1999, Journal of the Neurological Sciences.
[17] G. Fisher,et al. Free D-aspartate and D-alanine in normal and Alzheimer brain , 1991, Brain Research Bulletin.
[18] K. Jellinger,et al. Morphometry of the corpus callosum in normal aging and Alzheimer's disease. , 1991, Journal of neural transmission. Supplementum.
[19] A. Berardelli,et al. Altered response to rTMS in patients with Alzheimer's disease , 2006, Clinical Neurophysiology.
[20] R. Nardone,et al. Transcranial magnetic stimulation shows impaired transcallosal inhibition in Marchiafava–Bignami syndrome , 2006, European journal of neurology.
[21] G. Caruso,et al. Evaluation of the motor cortex by magnetic stimulation in patients with Alzheimer disease , 1996, Journal of the Neurological Sciences.
[22] Paolo Maria Rossini,et al. Motor cortex excitability in Alzheimer's disease: A transcranial magnetic stimulation study , 2003, Annals of neurology.
[23] A. Berardelli,et al. Changes in the cortical silent period after repetitive magnetic stimulation of cortical motor areas , 2000, Experimental Brain Research.
[24] N. Sims,et al. Cortical Pyramidal Neurone Loss May Cause Glutamatergic Hypoactivity and Cognitive Impairment in Alzheimer's Disease: Investigative and Therapeutic Perspectives , 1993, Journal of neurochemistry.
[25] D. Neary,et al. Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease , 1990, Neuroscience.
[26] E. Masliah,et al. Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease , 1996 .
[27] K. Shoumura,et al. Structural organization of ‘callosal’ OBg in human corpus callosum agenesis , 1975, Brain Research.
[28] Raffaele Ferri,et al. Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity , 2001, Neuroscience Letters.
[29] Robert Chen,et al. Short interval intracortical inhibition and facilitation during the silent period in human , 2007, The Journal of physiology.
[30] S. Rossi,et al. Clinical neurophysiology of aging brain: From normal aging to neurodegeneration , 2007, Progress in Neurobiology.
[31] J. Rothwell,et al. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation , 2002, Neurology.
[32] A. Nordberg,et al. Neuroreceptor changes in Alzheimer disease. , 1992, Cerebrovascular and brain metabolism reviews.
[33] M J Campbell,et al. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[34] Robert Chen,et al. Interactions between two different inhibitory systems in the human motor cortex , 2001, The Journal of physiology.
[35] G. Wilcock,et al. The cholinergic hypothesis of Alzheimer’s disease: a review of progress , 1999, Journal of neurology, neurosurgery, and psychiatry.
[36] K J Werhahn,et al. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans , 1999, The Journal of physiology.
[37] F Lepore,et al. Interhemispheric disconnection syndrome in Alzheimer's disease. , 1998, Proceedings of the National Academy of Sciences of the United States of America.